← Browse by Condition
Medical Condition

aortic valve stenosis

Total Trials
11
Recruiting Now
11
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for aortic valve stenosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — aortic valve stenosis Clinical Trials

How many clinical trials are currently recruiting for aortic valve stenosis?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for aortic valve stenosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for aortic valve stenosis?
aortic valve stenosis research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a aortic valve stenosis clinical trial?
Eligibility criteria for aortic valve stenosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Shanghai Zhongshan Hospital 1 trial
Medical University of Vienna 1 trial
Helios Health Institute GmbH 1 trial
Meril Life Sciences Pvt. Ltd. 1 trial
Montreal Heart Institute 1 trial

Recruiting Clinical Trials

NCT07145463
Recruiting
Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions
Enrollment
232 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
View Trial →
NCT07477002
Recruiting
Post-Dilatation in Balloon-Expandable TAVI Prostheses
Enrollment
146 pts
Location
Austria
Sponsor
Medical University of Vienna
View Trial →
NCT05015452
Recruiting
The Leipzig TAVI Registry
Enrollment
20,000 pts
Location
Germany
Sponsor
Helios Health Institute GmbH
View Trial →
NCT04703699
Recruiting
Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.
Enrollment
200 pts
Location
Estonia, Italy, Neth...
Sponsor
Meril Life Sciences Pvt. Ltd.
View Trial →
NCT03303612
Recruiting
Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI
Enrollment
250 pts
Location
Canada, France
Sponsor
Montreal Heart Institute
View Trial →
NCT06000943
Recruiting
Ischemic And Bleeding Risk Assessment After TAVR
Enrollment
2,500 pts
Location
Belgium, Chile, Czec...
Sponsor
Niguarda Hospital
View Trial →
NCT07016477
Recruiting
Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure
Enrollment
1,000 pts
Location
United States, Germa...
Sponsor
Semmelweis University
View Trial →
NCT07276711
Recruiting
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
Enrollment
663 pts
Location
United States
Sponsor
EmStop Inc
View Trial →
NCT05778773
Recruiting
OUTcomes Evaluation of Current Therapeutic STrategies for Severe Aortic Valve steNosis anD the agING Population in ITALY
Enrollment
1,000 pts
Location
Italy
Sponsor
IRCCS Policlinico S. Donato
View Trial →
NCT01805739
Recruiting
Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation
Enrollment
5,000 pts
Location
Germany
Sponsor
Klinik für Kardiologie, Pneumo...
View Trial →
NCT07626710
Recruiting
Impact of Trans-catheter Aortic Valve Implantation on Renal Function
Enrollment
1,000 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →

Related Conditions

left bundle branch block (1) transcatheter aortic valve replacement (1) coronary artery disease (1) tomography x ray computed (1) aortic stenosis (1) aortic valve disease (1) chronic kidney diseases (1) renal failure acute chronic (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology